Okay, here's a summary of the provided transcript, formatted as requested:
0:00-0:02 Introduction: Bio H3 presents its new interventional radiology sector, featuring multi-modality rooms. These rooms are the first of their kind in the Midi Pyrenees region.
0:02-0:05 Multimodality Approach: The rooms combine angiography, ultrasound, and fusion techniques to guide punctures and treatments with information from scanners and other imaging modalities.
0:05-0:10 Increased Performance: The goal is to improve the precision of interventions, directly targeting treatment areas using combined information sources from various imaging modes.
0:10-0:17 Interventional Radiology in France: Over 500,000 interventional radiology examinations are performed in France each year. The management and care of patients within this context is increasingly important, and the sector operates with similar constraints as operating rooms.
0:17-0:23 New Sector Components: The new sector includes three angiography rooms, one of which is a hybrid room for percutaneous vascular access. Also includes a dedicated scanner room.
0:23-0:27 Hybrid Room Capabilities: The hybrid room allows for complex procedures by associating different specialists, optimizing the performance of various treatments. It also includes the best available imaging guidance.
0:27-0:33 Range of Treatments: Interventional radiology addresses a wide range of conditions, including peripheral vessel obstructions, renal artery issues, aneurysms (visceral, peripheral, aortic) and related vascular pathologies. They also utilize branched prostheses for anatomical reconstruction.
0:33-0:40 Cancer Treatments: The sector also focuses on cancer treatments, including managing complications and direct tumor treatments. Chemotherapy can be directly applied to tumors.
0:40-0:45 Direct Puncture Techniques: The use of a scanner or ultrasound facilitates direct tumor destruction through percutaneous techniques.
0:45-0:50 New Scanner: The university hospital has a new scanner dedicated to interventional radiology that facilitates optimal conditions for treatments with a focus on patient asepsis and pain management.
0:50-0:59 Biopsies and Treatments: The scanner is used for biopsies for histological analysis and percutaneous treatments of tumors like hepatic, pulmonary, and renal.
0:59-1:02 Treatment Statistics: Around 250 treatments of this type are performed annually using radiofrequency and cryotherapy.
1:02-1:07 Impact on Prognosis: These minimally invasive treatments have revolutionized prognoses for metastatic patients, typically allowing patients to leave the hospital the day after a procedure.
1:07-1:10 Minimally Invasive Approach: Interventions involve needle punctures guided by scanners or ultrasounds with procedures lasting 5-25 minutes. Small kidney tumors have a 95-99% success rate.
1:10-1:15 Advances in Treatment: The combination of effective chemotherapies, ambitious surgeries, and minimally invasive percutaneous treatments are improving patient outcomes.
1:15-1:18 Sector Objectives: The aim of the sector is to improve performance through imaging guidance, reduce complications, and shorten hospitalization times.
1:18-1:20 Radiation Protection: Radiation protection is a focus, aiming to reduce irradiation for both patients and staff.
1:20-1:24 Collaborative Teams: The work is done in collaboration with surgical, anesthetic and other specialized teams in order to optimize the performance of the tools.